CoChat

Development of a miniaturized 3D organoid culture platform for ultra-high-throughput screening

Open access
Du, Yuhong, Li, Xingnan, Niu, Qiankun, Mo, Xiulei, Qui, Min, Ma, Tingxuan, Kuo, Calvin J, Fu, Haian · 2020 · Journal of Molecular Cell Biology

The DOI matches its Crossref record; 51 of the 53 references it cites were found in a registry or an index.

Abstract

The recent advent of robust methods to grow human tissues as 3D organoids allows us to recapitulate the 3D architecture of tumors in an in vitro setting and offers a new orthogonal approach for drug discovery. However, organoid culturing with extracellular matrix to support 3D architecture has been challenging for high-throughput screening (HTS)-based drug discovery due to technical difficulties. Using genetically engineered human colon organoids as a model system, here we report our effort to miniaturize such 3D organoid culture with extracellular matrix support in high-density plates to enable HTS. We first established organoid culturing in a 384-well plate format and validated its application in a cell viability HTS assay by screening a 2036-compound library. We further miniaturized the 3D organoid culturing in a 1536-well ultra-HTS format and demonstrated its robust performance for large-scale primary compound screening. Our miniaturized organoid culturing method may be adapted to other types of organoids. By leveraging the power of 3D organoid culture in a high-density plate format, we provide a physiologically relevant screening platform to model tumors to accelerate organoid-based research and drug discovery.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/jmcb/mjaa036

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Morphological evaluation and biochemical confirmation of human colon organoids from cryo-preserved frozen samples. (A) Recovered human colon APC−/−;KRASG12D organoids from frozen stocks. Frozen vials of organoids were thawed at 37°C, re-suspended in BME gel, and plated into a 24-well plate as a 50-µl droplet/well. The medium was refreshed every 3‒4 days. The growth of organoids was monitored with the ImageXpressmicro automated-imaging system (10× objective). (B) Robust growth of human colon APC−/−;KRASG12D organoids (4× objective). Representative images from two different wells of a 24-well plate are shown. All the images shown are merged images of Z-stack using ImageXpress software. (C) The KRASG12D protein expression of human colon APC−/−;KRASG12D organoids was confirmed in comparison to that of APC−/−;KRASWT organoids. Organoids were collected for western blotting analysis with anti-KRASG12D-specific antibody.
Figure 1 Morphological evaluation and biochemical confirmation of human colon organoids from cryo-preserved frozen samples. (A) Recovered human colon APC−/−;KRASG12D organoids from frozen stocks. Frozen vials of organoids were thawed at 37°C, re-suspended in BME gel, and plated into a 24-well plate as a 50-µl droplet/well. The medium was refreshed every 3‒4 days. The growth of organoids was monitored with the ImageXpressmicro automated-imaging system (10× objective). (B) Robust growth of human colon APC−/−;KRASG12D organoids (4× objective). Representative images from two different wells of a 24-well plate are shown. All the images shown are merged images of Z-stack using ImageXpress software. (C) The KRASG12D protein expression of human colon APC−/−;KRASG12D organoids was confirmed in comparison to that of APC−/−;KRASWT organoids. Organoids were collected for western blotting analysis with anti-KRASG12D-specific antibody.CC BY · PubMed Central
Figure 2 Culturing of human colon organoids in a 384-well plate format. (A) Scheme for miniaturizing organoid culture in a 384-well plate. Organoids growing in BME gel in the 24-well plate were collected and re-suspended in ice-cold BME gel. The organoid cells/BME gel mixture (8 µl/well) was dispensed into a 384-well plate. After incubation for 30 min at 37°C, warm organoid culture medium (35 µl) was dispensed to each well. The plate was incubated for up to 8 days without replacing the medium. (B) The organoids growing in a 384-well plate was monitored using ImageXpressmicro and showed progressing growth over the time. (C) The growth of organoids in 384-well plate was quantified by CellTiter Blue cell viability assay and showed robust FI signals for HTS with Zʹ of 0.7 and S/B ratio of 6.3.
Figure 2 Culturing of human colon organoids in a 384-well plate format. (A) Scheme for miniaturizing organoid culture in a 384-well plate. Organoids growing in BME gel in the 24-well plate were collected and re-suspended in ice-cold BME gel. The organoid cells/BME gel mixture (8 µl/well) was dispensed into a 384-well plate. After incubation for 30 min at 37°C, warm organoid culture medium (35 µl) was dispensed to each well. The plate was incubated for up to 8 days without replacing the medium. (B) The organoids growing in a 384-well plate was monitored using ImageXpressmicro and showed progressing growth over the time. (C) The growth of organoids in 384-well plate was quantified by CellTiter Blue cell viability assay and showed robust FI signals for HTS with Zʹ of 0.7 and S/B ratio of 6.3.CC BY · PubMed Central
Figure 3 Screening of the EEBL library with the human colon organoids in a 384-well plate format. Human colon APC−/−;KRASG12D organoids cultured in 384-well plates were treated with library compounds (0.1 µl, final at 4.6 µM). The plates were incubated for 3 days and subjected to CellTiter Blue cell viability assay. The effect of compounds on the growth of KRASG12D organoids was calculated as % Inhibition based on each plate and analyzed using Cambridge BioAssay software. (A and B) Performance evaluation with Zʹ factors (A) and S/B (B) across six 384-well screening plates. (C) Scatter plot of compound effects (% Inhibition) from the HTS. (D) An example plate hit map. (E) Correlation between two independent screens.
Figure 3 Screening of the EEBL library with the human colon organoids in a 384-well plate format. Human colon APC−/−;KRASG12D organoids cultured in 384-well plates were treated with library compounds (0.1 µl, final at 4.6 µM). The plates were incubated for 3 days and subjected to CellTiter Blue cell viability assay. The effect of compounds on the growth of KRASG12D organoids was calculated as % Inhibition based on each plate and analyzed using Cambridge BioAssay software. (A and B) Performance evaluation with Zʹ factors (A) and S/B (B) across six 384-well screening plates. (C) Scatter plot of compound effects (% Inhibition) from the HTS. (D) An example plate hit map. (E) Correlation between two independent screens.CC BY · PubMed Central
Figure 4 Dose‒response curves of selected top hits. (A‒C) Three proteasome inhibitors, bortezomib (A), carfilzomib (B), and MLN9708 (C), showed potent inhibitory effect on the growth of organoids. (D‒F) The PI3K/mTOR inhibitor PF04691502 (D), the survivin inhibitor YM155 (E), and the protein transporter inhibitor brefeldin A (F) inhibited organoid growth in a dose-dependent manner. Tested hit compounds were re-purchased for the dose‒response study. The effect of compounds on organoid growth was expressed as % of Control. Data shown are mean from triplicate samples with SD and analyzed using GraphPad Prism software.
Figure 4 Dose‒response curves of selected top hits. (A‒C) Three proteasome inhibitors, bortezomib (A), carfilzomib (B), and MLN9708 (C), showed potent inhibitory effect on the growth of organoids. (D‒F) The PI3K/mTOR inhibitor PF04691502 (D), the survivin inhibitor YM155 (E), and the protein transporter inhibitor brefeldin A (F) inhibited organoid growth in a dose-dependent manner. Tested hit compounds were re-purchased for the dose‒response study. The effect of compounds on organoid growth was expressed as % of Control. Data shown are mean from triplicate samples with SD and analyzed using GraphPad Prism software.CC BY · PubMed Central
Figure 5 Imaging analysis of cell fate of organoids in a 384-well plate format. Organoids growing in a 384-well plate (4 days) were treated with DMSO, MLN9708, or ABT-263 (5 µM) for 3 days. A combination of dyes diluted in PBS containing Hoechst 33342, Calcein-AM, and PI was added and incubated for 30 min. The bright field and fluorescence images were captured with the ImageXpressmicro automated imaging system using Z-stack. The representative merged images from Z-stack for DMSO control, MLN9708, and ABT-263 treatment are shown.
Figure 5 Imaging analysis of cell fate of organoids in a 384-well plate format. Organoids growing in a 384-well plate (4 days) were treated with DMSO, MLN9708, or ABT-263 (5 µM) for 3 days. A combination of dyes diluted in PBS containing Hoechst 33342, Calcein-AM, and PI was added and incubated for 30 min. The bright field and fluorescence images were captured with the ImageXpressmicro automated imaging system using Z-stack. The representative merged images from Z-stack for DMSO control, MLN9708, and ABT-263 treatment are shown.CC BY · PubMed Central
Figure 6 Miniaturized 3D organoid assays in a 1536-well plate format for uHTS. (A) Growth of human colon APC−/−;KRASG12D organoids in 1536-well vs. 384-well plates was compared. (B) The effect of compounds, ABT-263 as an example, exhibited very similar inhibitory effect on the growth of APC−/−;KRASG12D organoids between 384-well and 1536-well plate formats. (C) Performance evaluation for the uHTS viability assay with organoids showing Zʹ (>0.5) and S/B (>5) scores across the screening plates. (D) Scatter plot of primary screening of a 10240-diversity compound library in a 1536-well uHTS format. Screening data were analyzed using Cambridge BioAssay software. The effect of compounds on the growth of APC−/−;KRASG12D organoids was calculated as % Inhibition per plate.
Figure 6 Miniaturized 3D organoid assays in a 1536-well plate format for uHTS. (A) Growth of human colon APC−/−;KRASG12D organoids in 1536-well vs. 384-well plates was compared. (B) The effect of compounds, ABT-263 as an example, exhibited very similar inhibitory effect on the growth of APC−/−;KRASG12D organoids between 384-well and 1536-well plate formats. (C) Performance evaluation for the uHTS viability assay with organoids showing Zʹ (>0.5) and S/B (>5) scores across the screening plates. (D) Scatter plot of primary screening of a 10240-diversity compound library in a 1536-well uHTS format. Screening data were analyzed using Cambridge BioAssay software. The effect of compounds on the growth of APC−/−;KRASG12D organoids was calculated as % Inhibition per plate.CC BY · PubMed Central
Figure 7 Work flow of 3D organoid culture for compound screening in 384-well HTS and 1536-well uHTS formats.
Figure 7 Work flow of 3D organoid culture for compound screening in 384-well HTS and 1536-well uHTS formats.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 125

Metadata

Authors
Du, Y., Li, X., Niu, Q., Mo, X., Qui, M., Ma, T., Kuo, C. J., & Fu, H.
Affiliations
  • Emory University (US)
  • Stanford Medicine (US)
Corresponding author
Du, Yuhong
Venue
Journal of Molecular Cell Biology
Published
2020-07-17
Volume
12
Issue
8
Pages
630-643
ISSN
  • 1674-2788 (ISSN-L)
  • 1759-4685
OpenAlex
W3042505563
Cited by
125
References
53
Citations by year
2026: 19 · 2025: 26 · 2024: 24 · 2023: 23 · 2022: 18 · 2021: 13 · 2020: 2
FWCI
4.40
Type
journal article
Language
en
Open access
Locations
  • Journal of Molecular Cell Biology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • NCI Cancer Target Discovery and Development (1U01CA217875, 1U01CA217851)
  • RAS Synthetic Lethal Network (1U01CA199241)
  • Emory Lung Cancer SPORE
  • NIH (P50CA217691, UL1-TR002378)
  • Winship Cancer Institute (NIH 5P30CA138292)
  • Emory WHSC 10X Single Cell Sequencing Seed Grant
  • Emory Woodruff Health Sciences Center Synergy Award
  • Imagine, Innovate and Impact
  • Funds from the Emory School of Medicine
Topics
  • Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
  • Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Zebrafish Biomedical Research Applications
Keywords
3D organoids, colon organoids, high-throughput screening, ultra-high-throughput screening, 1536-well plates, 384-well plate, extracellular matrix, drug discovery, compound screening, tumor models
MeSH terms
Colon, Humans, Miniaturization, Organoids, Cryopreservation, Cell Culture Techniques, Imaging, Three-Dimensional, Cell Shape, High-Throughput Screening Assays

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.